5 AAPI scientists and innovators to know

May 20, 2021
Today, President Biden will sign important legislation addressing anti-Asian hate crimes. We applaud the law’s passage—and the important contributions of the AAPI community to innovation. Also, two of the best science communicators we know tells us more about the “bio…
BIO

Today, President Biden will sign important legislation addressing anti-Asian hate crimes. We applaud the law’s passage—and the important contributions of the AAPI community to innovation. Also, two of the best science communicators we know tells us more about the “bio-revolution,” and we recap yesterday's HHS appropriations hearing. (1078 words, 5 minutes, 23 seconds)

 

5 AAPI scientists and innovators to know

 
 

May is Asian American Pacific Islander Heritage Month, so today, as we applaud the passage of legislation addressing the rise in anti-Asian hate crimes, we’re also honoring the contributions to the sciences of so many members of the AAPI community.

This afternoon, President Biden will sign into law the COVID-19 Hate Crimes Act, which addresses the rise in anti-Asian hate crimes during the past year by designating a point person at Justice to expedite review of hate crimes related to COVID and providing new resources for reporting them, explains NPR

BIO celebrates the passage of this important legislation—and as we’ve written previously, the contributions of the AAPI community to the biotech sector, including in medicine, pharmaceutical, and medical manufacturing, and the food supply chain.

Here are five AAPI scientists and biotech innovators you should know: 

1. Isabella Aiona Abbott (1919-2010) was the first native Hawaiian woman to earn a Ph.D. and a Stanford marine botanist who became one of the world’s leading experts on “limu,” the Hawaiian word for seaweed. She was known for integrating seaweed into her cooking and educating others about Hawaiian culture by exposing them to its culinary traditions, which culminated in a pivotal 1987 article about her work in Gourmet. 

2. Steven Chu (1948-) is the first Chinese American to serve as the U.S. Secretary of Energy, as well as the first Nobel Prize winner and first scientist to be appointed to a cabinet position. Prior to serving as Energy Secretary (2009-2013), Chu was director of the Lawrence Berkeley National Laboratory, where he pursued alternative and renewable energy technologies. As a physics professor at Stanford University, he helped launch Bio-X, a multi-disciplinary institute combining the physical and biological sciences with medicine and engineering. Chu is the co-recipient of the 1997 Nobel Prize in Physics for his work on atom trapping and laser cooling. 

3. David Ho (1952-) is a virologist and physician whose HIV research in the 1990s led to breakthroughs in understanding how the virus replicates. Ho advocated for using drugs to stop HIV replication before patients got sick, which led in large part to HIV/AIDS becoming a chronic condition for many instead of a death sentence. In 1996, he was the first medical professional to be named the TIME Person of the Year. Today, he’s a microbiology and immunology professor and director of the Aaron Diamond AIDS Research Center at Columbia University; he’s also developing a drug that can interrupt the ability of COVID-19 to replicate. 

4. Ellison Onizuka (1946-1986) was the first Asian American in space, a member of NASA’s Astronaut Class of 1978. Prior to joining NASA, Colonel Onizuka had a distinguished career in the United States Air Force, where he was both a test pilot and a flight test engineer. His first space mission was aboard Space Shuttle Discovery in 1985. Sadly, Onizuka’s life was cut short on January 28, 1986, when Space Shuttle Challenger exploded 73 seconds after launch. 

5. Chien-Shiung Wu (1912-1997) was a nuclear physicist who worked on the Manhattan Project at Columbia University in 1944, just eight years after arriving to the U.S. from China. She was awarded the first-ever Wolf Prize in Physics for dismantling the idea that there was such a thing as perfect mathematical symmetry in all “subatomic processes,” in an experiment that would be known as the “Wu Experiment.” She also became the first person to prove the theory of beta decay. She advised fellow researchers Tsung-Dao Lee and Chen-Ning Yang through the “Wu Experiment,” for which they would win the 1957 Nobel Prize in Physics

Read: Confronting the Epidemic of Hate Against AAPI Communities

P.S. Today's International Clinical Trials Day, recognizing scientists who conduct clinical trials and the role they play in public health. But there’s still a lot of work to do to ensure clinical trials are inclusive. On June 24-25, BIO will host a special event, Building a Sustainable and Equitable Clinical Development Ecosystem—save the date!

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 

What is the bio-revolution?

 
 

BIO is working towards a “bio-revolution”—but what exactly does that mean? BIO’s Dr. Michelle McMurry-Heath and Jason Kelly, CEO of Gingko Bioworks, joined the McKinsey Global Institute’s Forward Thinking podcast to discuss. 

“We’ve heard about the Industrial Revolution and the digital revolution. We’re now heading into a Bio Revolution,” says McKinsey’s Michael Chui. 

This will “transform the economy and society” in a number of ways, from helping us better manage natural resources, to making medical research and care more precise and personalized, to improving the yield of agriculture. 

“The way Gingko thinks about the world is we think of biology as something that can be programmed, sort of like you’d program a computer,” explains Jason Kelly. Every cell has “digital code in the form of DNA,” which can be “programmed” to do new things—from producing plant-based “leather” or "plastic" or “burgers,” to developing personalized therapeutics.

Above all, the bio-revolution will help us solve some of our biggest challenges, says Dr. Michelle. “Almost every big issue we face today— global warming, clean air and water, access to nutritious foods, medical solutions—all those big unknown questions and big needs can be served by biotechnology.”

“If we think that is true, then we must figure out an equitable way to distribute that research and the fruit of that research once it’s achieved,” she continues. “What we really need is a grassroots movement of people who understand the importance of science in their lives, and who demand that policymakers show the political will and backbone to get the solutions to them.” 

The conversation is really good—listen to the whole thing.

Want more? Gingko’s Jason Kelly joined the I am BIO Podcast last year to talk about why synbio changes everything. You can learn more about the future of this technology on Gingko’s new website, www.syntheticbiology.com.

 

More Agriculture and Environment News: 

USDA: USDA Releases 90-Day Progress Report on Climate-Smart Agriculture and Forestry
The U.S. Department of Agriculture (USDA) just released its Climate-Smart Agriculture and Forestry Strategy: 90-Day Progress Report. A copy of the report is available here. BIO is reviewing to see how the recommendations we provided to USDA were incorporated into the report.

Futurity: Air pollution from cars is a risk factor for Alzheimer’s
“‘We saw that traffic-related air pollution accelerated Alzheimer’s disease characteristics not only in the animals who express the risk gene (which we anticipated) but also in the wild type rats,’ [UC Davis researcher Pamela] Lein says.”

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
BIO Beltway Report
BIO Beltway Report
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

President Biden’s Thursday: Signing the COVID-19 Hate Crimes Act into law. In other news, he reappointed Dr. Michael Kuperberg, the scientist responsible for the National Climate Assessment, who was removed from his post last year, reports The New York Times.

What’s Happening on Capitol Hill: Today, we're keeping an eye on a Senate Special Committee on Aging hearing, Taking Aim at Alzheimer’s: Frontline Perspectives and Caregiver Challenges (9:30 AM ET).

ICYMI: CDC Director Rochelle Walensky and outgoing Principal Deputy Director Anna Schuchat testified before the Senate Labor-HHS Subcommittee on Appropriations yesterday on the agency’s FY22 budget request.

Without the formal release of President Biden’s budget request, details on recommended funding levels were sparse, but Senators drilled down on getting commitments to fund a more robust public health infrastructure including workforce expansion, data modernization, and lab improvements.

Sen. Roy Blunt (R-MO) introduced some COVID-19 vaccine news when he asked Dr. Walensky if she was involved in a recent decision at BARDA to execute a purchase agreement for 400 million vaccine booster doses. Walensky stated she was not involved in that decision but cautioned that no plans for booster distribution have been made as the needs for such doses is still being studied. 

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook